244 related articles for article (PubMed ID: 27932667)
1. Lymph node yield is an independent predictor of survival in rectal cancer regardless of receipt of neoadjuvant therapy.
Xu Z; Berho ME; Becerra AZ; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JRT; Fleming FJ
J Clin Pathol; 2017 Jul; 70(7):584-592. PubMed ID: 27932667
[TBL] [Abstract][Full Text] [Related]
2. Implications of lymph node retrieval in locoregional rectal cancer treated with chemoradiotherapy: a California Cancer Registry Study.
Gill A; Brunson A; Lara P; Khatri V; Semrad TJ
Eur J Surg Oncol; 2015 May; 41(5):647-52. PubMed ID: 25800934
[TBL] [Abstract][Full Text] [Related]
3. Tumour stage and preoperative chemoradiotherapy influence the lymph node yield in stages I-III rectal cancer: results from a prospective nationwide cohort study.
Lykke J; Roikjaer O; Jess P;
Colorectal Dis; 2014 Apr; 16(4):O144-9. PubMed ID: 24329928
[TBL] [Abstract][Full Text] [Related]
4. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
Xu Z; Mohile SG; Tejani MA; Becerra AZ; Probst CP; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JR; Fleming FJ
Cancer; 2017 Jan; 123(1):52-61. PubMed ID: 27560162
[TBL] [Abstract][Full Text] [Related]
5. Resected irradiated rectal cancers: Are twelve lymph nodes really necessary in the era of neoadjuvant therapy?
Cox ML; Adam MA; Shenoi MM; Turner MC; Sun Z; Mantyh CR; Migaly J
Am J Surg; 2018 Sep; 216(3):444-449. PubMed ID: 28890055
[TBL] [Abstract][Full Text] [Related]
6. Increased lymph node yield indicates improved survival in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Wang Y; Zhou M; Yang J; Sun X; Zou W; Zhang Z; Zhang J; Shen L; Yang L; Zhang Z
Cancer Med; 2019 Aug; 8(10):4615-4625. PubMed ID: 31250569
[TBL] [Abstract][Full Text] [Related]
7. Increased Lymph Node Yield Is Associated With Improved Survival in Rectal Cancer Irrespective of Neoadjuvant Treatment: Results From a National Cohort Study.
Lykke J; Jess P; Roikjaer O;
Dis Colon Rectum; 2015 Sep; 58(9):823-30. PubMed ID: 26252843
[TBL] [Abstract][Full Text] [Related]
8. Pathologic Complete Response Despite Nodal Yield Has Best Survival in Locally Advanced Rectal Cancer.
Narayanan S; Attwood K; Gabriel E; Nurkin S
J Surg Res; 2020 Jul; 251():220-227. PubMed ID: 32172008
[TBL] [Abstract][Full Text] [Related]
9. Role of lymph node yield and lymph node ratio in predicting outcomes in non-metastatic colorectal cancer.
Lee CHA; Wilkins S; Oliva K; Staples MP; McMurrick PJ
BJS Open; 2019 Feb; 3(1):95-105. PubMed ID: 30734020
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of lymph node yield in ypN0 rectal cancer.
Raoof M; Nelson RA; Nfonsam VN; Warneke J; Krouse RS
Br J Surg; 2016 Nov; 103(12):1731-1737. PubMed ID: 27507796
[TBL] [Abstract][Full Text] [Related]
11. Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands.
Visser E; van Rossum PSN; Ruurda JP; van Hillegersberg R
Ann Surg; 2017 Nov; 266(5):863-869. PubMed ID: 28742691
[TBL] [Abstract][Full Text] [Related]
12. Impact of Lymph Node Yield on Survival in Surgically Treated Oropharyngeal Squamous Cell Carcinoma.
Gomez ED; Chang JC; Ceremsak JJ; Brody RM; Brant JA; Rassekh CH; Weinstein GS; Newman JG
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):146-156. PubMed ID: 32689888
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Management of Pathologic Node-Positive Disease After Definitive Surgery for Clinical T1-2 N0 Rectal Cancer.
Polamraju P; Haque W; Verma V; Wiederhold L; Hatch S; Butler EB; Teh BS
Clin Colorectal Cancer; 2018 Sep; 17(3):e519-e530. PubMed ID: 29753642
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy.
Abdel-Misih SR; Wei L; Benson AB; Cohen S; Lai L; Skibber J; Wilkinson N; Weiser M; Schrag D; Bekaii-Saab T
J Natl Compr Canc Netw; 2016 Dec; 14(12):1528-1534. PubMed ID: 27956537
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant therapy does not affect lymph node ratio in rectal cancer.
Chang KH; Kelly NP; Duff GP; Condon ET; Waldron D; Coffey JC
Surgeon; 2016 Oct; 14(5):270-3. PubMed ID: 26148760
[TBL] [Abstract][Full Text] [Related]
16. A minimum yield of twelve lymph nodes in rectal cancer remains valid in the era of neo-adjuvant treatment : results from a national cohort study.
Lykke J; Jess P; Roikjaer O;
Int J Colorectal Dis; 2015 Mar; 30(3):347-51. PubMed ID: 25652878
[TBL] [Abstract][Full Text] [Related]
17. Influence of age and site of disease on lymph node yield in colorectal cancer.
Ahmadi O; Stringer MD; Black MA; McCall JL
N Z Med J; 2014 Jun; 127(1395):31-40. PubMed ID: 24929691
[TBL] [Abstract][Full Text] [Related]
18. Lymph node yield after rectal resection is a predictor of survival among patients with node-negative rectal adenocarcinoma.
Bliggenstorfer JT; Ginesi M; Steinhagen E; Stein SL
Surgery; 2022 Nov; 172(5):1292-1299. PubMed ID: 35260248
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status.
Kulaylat AS; Hollenbeak CS; Stewart DB
Ann Surg Oncol; 2017 May; 24(5):1281-1288. PubMed ID: 27864695
[TBL] [Abstract][Full Text] [Related]
20. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
